The IP Law Blog
FEBRUARY 2, 2023
Design patents and utility patents are two different things. Design patents protect ornamental designs, such as the shape of a perfume bottle or the design on flatware. To be patentable, however, both designs and functional inventions must satisfy two requirements. Telflex, Inc.,
Patently-O
FEBRUARY 24, 2022
20-891 (CVSG requested May 3, 2021); Res Judicata and the Patent-Specific Kessler Doctrine : PersonalWeb Technologies, LLC v. 20-1394 (CVSG requested October 4, 2021); Undermining Jury Decisions : Olaf Sööt Design, LLC v. The fourth and final case with a pending CVSG is Olaf Sööt Design, LLC v. Neapco Holdings LLC, et al. ,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Patently-O
OCTOBER 25, 2021
This guest post was authored by Joel Smith, a 3L at the University of Missouri School of Law, with support from the team at the Mizzou Law Veterans Clinic. Why is there a post about a veterans law case on a patent law blog? Mr. Taylor did so in early 2007. In Burris v. Wilkie , 888 F.3d 3d 1352 (Fed.
Patently-O
MARCH 28, 2024
The Motivation to Combine: In patent law, the “motivation to combine” doctrine plays a central role in determining whether a claimed invention is obvious under our guiding statute, 35 U.S.C. § In the case, the IPR petitioner failed to articulate that reasoning and thus the PTAB’s obviousness finding was improper.
IP and Legal Filings
MARCH 27, 2024
Introduction The main emphasis of the case pertains to accusations of patent infringement made by the defendant, as well as the subsequent pursuit of damages. In year 2007 the plaintiffs (Bajaj Auto Ltd.) of violating their patents related to the development of “enhanced internal combustion engine technology”. 1903 RPC 225.
Patently-O
APRIL 16, 2024
M]erely describing the design of an experiment in a ClinicalTrial.Gov disclosure tells a POSA nothing about the obviousness of the study’s eventual result. In its brief, Vanda argues that: clinical trials are far from a sure thing – indeed, most drug trials fail. [M]erely
Patently-O
JUNE 30, 2023
by Dennis Crouch Design patents continue to rise in importance, but the underlying law full of eccentricities. The crux of the issue lies in the manner patent law decisions are typically written. 398 (2007), overrule or abrogate In re Rosen, 673 F.2d The case under scrutiny is LKQ Corp. Teleflex Inc.,
Expert insights. Personalized for you.
98 
Let's personalize your content